Projeto
Molecular epidemiology, drug resistance and pathogenesis of HIV and TB in Angola: the Angolan PErinatal HIV Cohort (APEHC)
| Referência: | PTDC/SAU-EPI/122400/2010 |
|---|---|
| Programa de financiamento: | 3599-PPCDT |
| Organização financiadora: | Fundação para a Ciência e a Tecnologia |
| Instituições associadas: | Universidade de Lisboa |
Registos relacionados
EPIDEMIOLOGY, PATHOGENESIS AND DETERMINANTS OF HIV-1 TRANSMISSION AND DISEASE PROGRESSION IN THE ANGOLAN PERINATAL HIV COHORT APEHC
HIV EPIDEMIOLOGY AND PATHOGENESIS IN WOMEN AND CHILDREN IN LUANDA, ANGOLA
Collaborative HIV and Anti-HIV Drug Resistance Network
European Network of HIV/AIDS Cohort Studies to Coordinate at European and International Level Clinical Research on HIV/AIDS
Deciphering the role of extracellular membrane vesicles in dissemination of HIV, CNS colonization and pathogenesis of HIV-associated neurologic disorders
Viral surface glycoproteins as potential drug targets against HIV-1 and HIV-2 infections
HIV IMMUNOPATHOGENESIS: COMPARISON OF THE IMPACT OF HIV-2 AND HIV-1 INFECTIONS IN LYMPHOID TISSUES.
Susceptibility of non-subtype B HIV-1 and HIV-2 isolates to entry inhibitors: identification and characterization of new pathways of resistance.
Investigation of the genetic diversity and drug susceptibility of HIV-1 in Maputo, Mozambique
Quantitative Studies of HIV Latency
HIV-2 interaction with macrophages and dendritic cells: implications in the reduced pathogenicity of HIV-2
Metallodendrimers as HIV antiviral and anticancer agents.
COMBINATION ANTIRETROVIRAL DRUG/SIRNA-LOADED TARGETED NANOCARRIERS FOR PREVENTING VAGINAL HIV TRANSMISSION
COMBINATION ANTIRETROVIRAL DRUG/SIRNA-LOADED TARGETED NANOCARRIERS FOR PREVENTING VAGINAL HIV TRANSMISSION
Application of massive parallel sequencing to microRNA profiling of cellular and molecular response to HIV-1 and HIV-2 infection and to modulation of integration
Minimizing the emergence and dissemination of HIV-1 drug resistance in PALOPs through an evidence-based portable high-throughput sequencing and computational approach.
DEVELOPMENT AND PRE-CLINICAL EVALUATION OF A NEW MICROBICIDE GEL FOR THE PREVENTION OF HIV-1 AND HIV-2 INFECTION
Sex-based differences in HIV-T cell interaction
Harmonizing, Integrating and Vitalizing European Research on hiv/Aids
Gene therapy for HIV cure using RNA replicons.
Cell membrane features in HIV entry and its inhibition
Artificial Zinc-Finger transcription factors libraries: Identification of HIV-1 cellular restriction factors and Therapeutic application in HIV-1 infection.
MULTI-TARGET HIV ENTRY INHIBITORS DELIVERY BY CATIONIC LIPOSOMES
Achieving gut integrity in HIV/AIDS through IL-22
HIV/AIDS: contribute of naïve CD4 T cell homeostasis
Multi-target HIV entry inhibitors delivery by cationic liposomes
NANOTECHNOLOGY-BASED STRATEGIES FOR RECTAL ANTI-HIV PRE-EXPOSURE PROPHYLAXIS
ENGINEERING SYNTHETIC DOMAIN ANTIBODIES WITH BROAD AND POTENT HIV-1 NEUTRALIZATION
ERADICATION OF HIV-1 INFECTED CELLS BY TARGETING NANOPARTICLES CARRYING THERAPEUTIC PLASMIDS
COMPARATIVE STUDY OF THE SELECTIVE PRESSURE, REPLICATION AND TRANSMISSION DYNAMICS OF HIV-1 SUBTYPES
Development and pre-clinical evaluation of a new HIV-1 vaccine concept
DEVELOPMENT AND PRE-CLINICAL EVALUATION OF A NEW HIV-1 VACCINE CONCEPT
Towards the development of innovative highly effective dual action anti-HIV peptides
Most at risk populations for HIV – is there a role for PrEP in the preventive armamentarium
Bolsa Sabática FCT: A clinical, radiological and pathophysiological study of chronic obstructive lung disease in a cohort of patients with HIV infection receiving antiretroviral treatment [SFRH/BSAB/976/2010]
Developing host-directed-therapies for Mycobacterium tuberculosis infection and HIV co-infection based on Cystatins manipulation
Publicações relacionadas
Carregando publicações...